Hims & Hers announced its plans to introduce at-home lab testing through its platform. The company has acquired an at-home lab testing facility, Sigmund NJ marketed as Trybe Labs, which will allow Hims & Hers to support at-home blood draws and more comprehensive whole-body testing. Sigmund NJ LLC, marketed as Trybe Labs, is located in New Jersey. Hims & Hers funded the acquisition through cash on hand. The acquisition is complete, and Hims & Hers expects to roll out at-home testing to customers over the next year.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers price target raised to $68 from $38 at Canaccord
- Optimistic Growth Outlook for Hims & Hers Health Amid Strategic Advancements and Regulatory Support
- HIMS Stock Slips after Catching a Downgrade from Morgan Stanley
- Delta flight crashes in Toronto, Southwest cuts corporate roles: Morning Buzz
- Hims & Hers price target raised to $85 from $35 at BTIG